Newswire

Newswire

Global RAS Targeting Therapies Market Report 2023-2031 with Profiles of Amgen, GlobeImmune, Jacobio Pharmaceuticals, Mirati Therapeutics, Novartis, Onconova Therapeutics, Targovax, Verastem Oncology

DUBLIN, Nov. 9, 2023 /PRNewswire/ — The “RAS Targeting Therapies by Target Indication, Type of Molecule, Type of Therapy, and Route of Administration, Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2031“ report has been added to ResearchAndMarkets.com’s offering. The…